ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antibody Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-39V1652
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antibody Drugs Market Insights Forecast to 2028
BUY CHAPTERS

Global Antibody Drugs Market Research Report 2025

Code: QYRE-Auto-39V1652
Report
September 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Amgen Inc
Bristol–Myers Squibb
F.Hoffmann-La Roche
Johnson & Johnson
AbbVie
Eli Lilly
Pfizer Inc
Bayer
GlaxoSmithKline PLC
Sanofi
Johnson & Johnson

Antibody Drugs Market Size

The global market for Antibody Drugs was valued at US$ 152940 million in the year 2024 and is projected to reach a revised size of US$ 280620 million by 2031, growing at a CAGR of 9.2% during the forecast period.

Antibody Drugs Market

Antibody Drugs Market

This report mainly focuses on antibody drugs market. Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antibody Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Drugs.
The Antibody Drugs market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antibody Drugs Market Report

Report Metric Details
Report Name Antibody Drugs Market
Accounted market size in year US$ 152940 million
Forecasted market size in 2031 US$ 280620 million
CAGR 9.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Amgen, Bristol-Myers Squibb, F. Hoffmann-La Roche, Johnson & Johnson, AbbVie, Eli Lilly, Pfizer, Bayer, GlaxoSmithKline, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antibody Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antibody Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Antibody Drugs Market growing?

Ans: The Antibody Drugs Market witnessing a CAGR of 9.2% during the forecast period 2025-2031.

What is the Antibody Drugs Market size in 2031?

Ans: The Antibody Drugs Market size in 2031 will be US$ 280620 million.

Who are the main players in the Antibody Drugs Market report?

Ans: The main players in the Antibody Drugs Market are Novartis, Amgen, Bristol-Myers Squibb, F. Hoffmann-La Roche, Johnson & Johnson, AbbVie, Eli Lilly, Pfizer, Bayer, GlaxoSmithKline, Sanofi

What are the Application segmentation covered in the Antibody Drugs Market report?

Ans: The Applications covered in the Antibody Drugs Market report are Central Nervous System (CNS) Disorders, Cancers, Autoimmune Disorders, Cardiovascular Diseases

What are the Type segmentation covered in the Antibody Drugs Market report?

Ans: The Types covered in the Antibody Drugs Market report are Monoclonal Antibodies, Antibody-Drug Conjugates, Polyclonal Antibodies

Recommended Reports

Antibody & Immunotherapy

Chronic & Autoimmune

Anti-Infectives & Allergy

1 Antibody Drugs Market Overview
1.1 Product Definition
1.2 Antibody Drugs by Type
1.2.1 Global Antibody Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal Antibodies
1.2.3 Antibody-Drug Conjugates
1.2.4 Polyclonal Antibodies
1.3 Antibody Drugs by Application
1.3.1 Global Antibody Drugs Market Value by Application (2024 VS 2031)
1.3.2 Central Nervous System (CNS) Disorders
1.3.3 Cancers
1.3.4 Autoimmune Disorders
1.3.5 Cardiovascular Diseases
1.4 Global Antibody Drugs Market Size Estimates and Forecasts
1.4.1 Global Antibody Drugs Revenue 2020-2031
1.4.2 Global Antibody Drugs Sales 2020-2031
1.4.3 Global Antibody Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antibody Drugs Market Competition by Manufacturers
2.1 Global Antibody Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antibody Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antibody Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antibody Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antibody Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antibody Drugs, Product Type & Application
2.7 Global Key Manufacturers of Antibody Drugs, Date of Enter into This Industry
2.8 Global Antibody Drugs Market Competitive Situation and Trends
2.8.1 Global Antibody Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antibody Drugs Players Market Share by Revenue
2.8.3 Global Antibody Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antibody Drugs Market Scenario by Region
3.1 Global Antibody Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antibody Drugs Sales by Region: 2020-2031
3.2.1 Global Antibody Drugs Sales by Region: 2020-2025
3.2.2 Global Antibody Drugs Sales by Region: 2026-2031
3.3 Global Antibody Drugs Revenue by Region: 2020-2031
3.3.1 Global Antibody Drugs Revenue by Region: 2020-2025
3.3.2 Global Antibody Drugs Revenue by Region: 2026-2031
3.4 North America Antibody Drugs Market Facts & Figures by Country
3.4.1 North America Antibody Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antibody Drugs Sales by Country (2020-2031)
3.4.3 North America Antibody Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antibody Drugs Market Facts & Figures by Country
3.5.1 Europe Antibody Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antibody Drugs Sales by Country (2020-2031)
3.5.3 Europe Antibody Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antibody Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Antibody Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antibody Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Antibody Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antibody Drugs Market Facts & Figures by Country
3.7.1 Latin America Antibody Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antibody Drugs Sales by Country (2020-2031)
3.7.3 Latin America Antibody Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antibody Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Antibody Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antibody Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antibody Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antibody Drugs Sales by Type (2020-2031)
4.1.1 Global Antibody Drugs Sales by Type (2020-2025)
4.1.2 Global Antibody Drugs Sales by Type (2026-2031)
4.1.3 Global Antibody Drugs Sales Market Share by Type (2020-2031)
4.2 Global Antibody Drugs Revenue by Type (2020-2031)
4.2.1 Global Antibody Drugs Revenue by Type (2020-2025)
4.2.2 Global Antibody Drugs Revenue by Type (2026-2031)
4.2.3 Global Antibody Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Antibody Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antibody Drugs Sales by Application (2020-2031)
5.1.1 Global Antibody Drugs Sales by Application (2020-2025)
5.1.2 Global Antibody Drugs Sales by Application (2026-2031)
5.1.3 Global Antibody Drugs Sales Market Share by Application (2020-2031)
5.2 Global Antibody Drugs Revenue by Application (2020-2031)
5.2.1 Global Antibody Drugs Revenue by Application (2020-2025)
5.2.2 Global Antibody Drugs Revenue by Application (2026-2031)
5.2.3 Global Antibody Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Antibody Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Antibody Drugs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Antibody Drugs Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Bristol-Myers Squibb
6.3.1 Bristol-Myers Squibb Company Information
6.3.2 Bristol-Myers Squibb Description and Business Overview
6.3.3 Bristol-Myers Squibb Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bristol-Myers Squibb Antibody Drugs Product Portfolio
6.3.5 Bristol-Myers Squibb Recent Developments/Updates
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Company Information
6.4.2 F. Hoffmann-La Roche Description and Business Overview
6.4.3 F. Hoffmann-La Roche Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 F. Hoffmann-La Roche Antibody Drugs Product Portfolio
6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Johnson & Johnson Antibody Drugs Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 AbbVie
6.6.1 AbbVie Company Information
6.6.2 AbbVie Description and Business Overview
6.6.3 AbbVie Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AbbVie Antibody Drugs Product Portfolio
6.6.5 AbbVie Recent Developments/Updates
6.7 Eli Lilly
6.7.1 Eli Lilly Company Information
6.7.2 Eli Lilly Description and Business Overview
6.7.3 Eli Lilly Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Eli Lilly Antibody Drugs Product Portfolio
6.7.5 Eli Lilly Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer Antibody Drugs Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer Antibody Drugs Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Company Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GlaxoSmithKline Antibody Drugs Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates
6.11 Sanofi
6.11.1 Sanofi Company Information
6.11.2 Sanofi Description and Business Overview
6.11.3 Sanofi Antibody Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sanofi Antibody Drugs Product Portfolio
6.11.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antibody Drugs Industry Chain Analysis
7.2 Antibody Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antibody Drugs Production Mode & Process Analysis
7.4 Antibody Drugs Sales and Marketing
7.4.1 Antibody Drugs Sales Channels
7.4.2 Antibody Drugs Distributors
7.5 Antibody Drugs Customer Analysis
8 Antibody Drugs Market Dynamics
8.1 Antibody Drugs Industry Trends
8.2 Antibody Drugs Market Drivers
8.3 Antibody Drugs Market Challenges
8.4 Antibody Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Amgen Inc
Bristol–Myers Squibb
F.Hoffmann-La Roche
Johnson & Johnson
AbbVie
Eli Lilly
Pfizer Inc
Bayer
GlaxoSmithKline PLC
Sanofi
Johnson & Johnson
List of Tables
 Table 1. Global Antibody Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Antibody Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Antibody Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Antibody Drugs Sales (g) of Key Manufacturers (2020-2025)
 Table 5. Global Antibody Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Antibody Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Antibody Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Antibody Drugs Average Price (USD/mg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Antibody Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Antibody Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Antibody Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Antibody Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antibody Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antibody Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Antibody Drugs Sales by Region (2020-2025) & (g)
 Table 18. Global Antibody Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Antibody Drugs Sales by Region (2026-2031) & (g)
 Table 20. Global Antibody Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Antibody Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Antibody Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Antibody Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Antibody Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Antibody Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Antibody Drugs Sales by Country (2020-2025) & (g)
 Table 27. North America Antibody Drugs Sales by Country (2026-2031) & (g)
 Table 28. North America Antibody Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Antibody Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Antibody Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Antibody Drugs Sales by Country (2020-2025) & (g)
 Table 32. Europe Antibody Drugs Sales by Country (2026-2031) & (g)
 Table 33. Europe Antibody Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Antibody Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Antibody Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Antibody Drugs Sales by Region (2020-2025) & (g)
 Table 37. Asia Pacific Antibody Drugs Sales by Region (2026-2031) & (g)
 Table 38. Asia Pacific Antibody Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Antibody Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Antibody Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Antibody Drugs Sales by Country (2020-2025) & (g)
 Table 42. Latin America Antibody Drugs Sales by Country (2026-2031) & (g)
 Table 43. Latin America Antibody Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antibody Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Antibody Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Antibody Drugs Sales by Country (2020-2025) & (g)
 Table 47. Middle East and Africa Antibody Drugs Sales by Country (2026-2031) & (g)
 Table 48. Middle East and Africa Antibody Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Antibody Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Antibody Drugs Sales (g) by Type (2020-2025)
 Table 51. Global Antibody Drugs Sales (g) by Type (2026-2031)
 Table 52. Global Antibody Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Antibody Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Antibody Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Antibody Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Antibody Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Antibody Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Antibody Drugs Price (USD/mg) by Type (2020-2025)
 Table 59. Global Antibody Drugs Price (USD/mg) by Type (2026-2031)
 Table 60. Global Antibody Drugs Sales (g) by Application (2020-2025)
 Table 61. Global Antibody Drugs Sales (g) by Application (2026-2031)
 Table 62. Global Antibody Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Antibody Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Antibody Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Antibody Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Antibody Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Antibody Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Antibody Drugs Price (USD/mg) by Application (2020-2025)
 Table 69. Global Antibody Drugs Price (USD/mg) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 73. Novartis Antibody Drugs Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Amgen Company Information
 Table 76. Amgen Description and Business Overview
 Table 77. Amgen Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 78. Amgen Antibody Drugs Product
 Table 79. Amgen Recent Developments/Updates
 Table 80. Bristol-Myers Squibb Company Information
 Table 81. Bristol-Myers Squibb Description and Business Overview
 Table 82. Bristol-Myers Squibb Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 83. Bristol-Myers Squibb Antibody Drugs Product
 Table 84. Bristol-Myers Squibb Recent Developments/Updates
 Table 85. F. Hoffmann-La Roche Company Information
 Table 86. F. Hoffmann-La Roche Description and Business Overview
 Table 87. F. Hoffmann-La Roche Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 88. F. Hoffmann-La Roche Antibody Drugs Product
 Table 89. F. Hoffmann-La Roche Recent Developments/Updates
 Table 90. Johnson & Johnson Company Information
 Table 91. Johnson & Johnson Description and Business Overview
 Table 92. Johnson & Johnson Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 93. Johnson & Johnson Antibody Drugs Product
 Table 94. Johnson & Johnson Recent Developments/Updates
 Table 95. AbbVie Company Information
 Table 96. AbbVie Description and Business Overview
 Table 97. AbbVie Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 98. AbbVie Antibody Drugs Product
 Table 99. AbbVie Recent Developments/Updates
 Table 100. Eli Lilly Company Information
 Table 101. Eli Lilly Description and Business Overview
 Table 102. Eli Lilly Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 103. Eli Lilly Antibody Drugs Product
 Table 104. Eli Lilly Recent Developments/Updates
 Table 105. Pfizer Company Information
 Table 106. Pfizer Description and Business Overview
 Table 107. Pfizer Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 108. Pfizer Antibody Drugs Product
 Table 109. Pfizer Recent Developments/Updates
 Table 110. Bayer Company Information
 Table 111. Bayer Description and Business Overview
 Table 112. Bayer Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 113. Bayer Antibody Drugs Product
 Table 114. Bayer Recent Developments/Updates
 Table 115. GlaxoSmithKline Company Information
 Table 116. GlaxoSmithKline Description and Business Overview
 Table 117. GlaxoSmithKline Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 118. GlaxoSmithKline Antibody Drugs Product
 Table 119. GlaxoSmithKline Recent Developments/Updates
 Table 120. Sanofi Company Information
 Table 121. Sanofi Description and Business Overview
 Table 122. Sanofi Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 123. Sanofi Antibody Drugs Product
 Table 124. Sanofi Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Antibody Drugs Distributors List
 Table 128. Antibody Drugs Customers List
 Table 129. Antibody Drugs Market Trends
 Table 130. Antibody Drugs Market Drivers
 Table 131. Antibody Drugs Market Challenges
 Table 132. Antibody Drugs Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antibody Drugs
 Figure 2. Global Antibody Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antibody Drugs Market Share by Type: 2024 & 2031
 Figure 4. Monoclonal Antibodies Product Picture
 Figure 5. Antibody-Drug Conjugates Product Picture
 Figure 6. Polyclonal Antibodies Product Picture
 Figure 7. Global Antibody Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Antibody Drugs Market Share by Application: 2024 & 2031
 Figure 9. Central Nervous System (CNS) Disorders
 Figure 10. Cancers
 Figure 11. Autoimmune Disorders
 Figure 12. Cardiovascular Diseases
 Figure 13. Global Antibody Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Antibody Drugs Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Antibody Drugs Sales (2020-2031) & (g)
 Figure 16. Global Antibody Drugs Average Price (USD/mg) & (2020-2031)
 Figure 17. Antibody Drugs Report Years Considered
 Figure 18. Antibody Drugs Sales Share by Manufacturers in 2024
 Figure 19. Global Antibody Drugs Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Antibody Drugs Players: Market Share by Revenue in Antibody Drugs in 2024
 Figure 21. Antibody Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Antibody Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Antibody Drugs Sales Market Share by Country (2020-2031)
 Figure 24. North America Antibody Drugs Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Antibody Drugs Sales Market Share by Country (2020-2031)
 Figure 28. Europe Antibody Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Antibody Drugs Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Antibody Drugs Revenue Market Share by Region (2020-2031)
 Figure 36. China Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Antibody Drugs Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Antibody Drugs Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Antibody Drugs Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Antibody Drugs Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Antibody Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Antibody Drugs by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Antibody Drugs by Type (2020-2031)
 Figure 58. Global Antibody Drugs Price (USD/mg) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Antibody Drugs by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Antibody Drugs by Application (2020-2031)
 Figure 61. Global Antibody Drugs Price (USD/mg) by Application (2020-2031)
 Figure 62. Antibody Drugs Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Antibody Market Insights Forecast to 2030
Global Antibody Production Services Market Research Report 2024
Global Anti HA Antibody Market Research Report 2024
Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024
Monoclonal Antibody Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Monoclonal Antibody Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biologics Monoclonal Antibodies Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Monoclonal Antibody Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Monoclonal Antibodies Market Research Report 2024
Global Monoclonal Antibodies Product Market Research Report 2024
Global Aβ Monoclonal Antibody Drug Market Research Report 2024
CD38 Monoclonal Antibody Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Monoclonal antibodies mAbs Biosimilars Market Research Report 2024
Global Next Generation Antibody Drug Market Research Report 2024
Monoclonal Mouse Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Next Generation Monoclonal Antibodies Market Research Report 2024
Global Monoclonal Antibody for Multiple Myeloma Market Research Report 2024
Global Cancer Monoclonal Antibody Partnering Terms and Agreements Market Insights Forecast to 2030
Global Monoclonal Antibodies Sterile Injectable Drugs Market Research Report 2024

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions